The Provincial Administrative Court in Warsaw confirmed that the pharmaceutical company has the right to reduce the VAT base amount, and consequently the VAT amount, due to the payment of rebates to the National Health Fund (NFZ).
Source: michaelamerz.org
Latest Posts in "Poland"
- KSeF Simplifies Tax Settlements: Digital Transformation’s Impact on Poland’s Investment Attractiveness
- Launch of open testing for KSeF 2.0 API
- Export Customs Clearance: Required Documents and Key Applications
- Poland Releases KSeF 2.0 Updates
- Proposed VAT Act Amendments: Agricultural Registration, 0% Rate, Inventory Changes, and Group Operation Extensions
